Concepedia

Michela Libertini

ML

Statistics

Publications

12

Citations

884

H-Index

12

Active since

2012

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

Imperial College London

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

Ca' Foncello Hospital

Vall d'Hebron Hospital Universitari

Michela Libertini is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in oncology, medicine, and sars-cov-2 infection.

ORCID

Publications per year

2012–2023

12

Publications

12

Sunitinib malate in solitary fibrous tumor (SFT)

Silvia Stacchiotti, Tiziana Negri, Michela Libertini et al. · Annals of Oncology · 2012 · 171 citations · Full text

, , +9

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

David J. Pinato, Mark Bower, Lorenza Scotti et al. · The Lancet Oncology · 2021 · 136 citations · Full text

, , +6

Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients

Giacomo Giulio Baldi, Silvia Stacchiotti, Valentina Mauro et al. · Clinical Sarcoma Research · 2013 · 105 citations · Full text

, , +12

Response to chemotherapy of solitary fibrous tumour: A retrospective study

Silvia Stacchiotti, Michela Libertini, Tiziana Negri et al. · European Journal of Cancer · 2013 · 95 citations

, , +3

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

Joris van de Haar, Xuhui Ma, Salo Ooft et al. · Nature Medicine · 2023 · 84 citations · Full text

, , +17

1–5 of 12